Antirheumatic Indications: NSAIDs

ANTIRHEUMATIC INDICATIONS: NSAIDS
Generic Brand Strength Form Indications
Osteo-arthritis Rheumatoid arthritis Ankylosing
spondylitis
Juvenile
idiopathic arthritis
Gouty arthritis
ACETIC ACIDS DERIVATIVES
diclofenac potassium 50mg tabs
diclofenac sodium 25mg, 50mg, 75mg e-c tabs
100mg ext-rel tabs
Zorvolex 35mg caps
etodolac 200mg, 300mg caps
400mg, 500mg tabs
400mg, 500mg, 600mg ext-rel tabs
indometh
acin
25mg, 50mg caps
75mg ext-rel caps
50mg rectal supp
Indocin 25mg/
 
5mL
susp
nabume
tone
500mg, 750mg tabs
sulindac 150mg, 200mg scored tabs
COX-2 INHIBITORS
celecoxib Celebrex 50mg, 100mg, 200mg, 400mg caps
PROPIONIC ACIDS DERIVATIVES
fenoprofen Nalfon 200mg, 400mg caps
flurbiprofen 100mg tabs
ibuprofen OTC 50mg, 100mg chewable tabs
400mg, 600mg, 800mg tabs
ketoprofen 200mg ext-rel caps*
naproxen Anaprox DS 550mg tabs
Naprelan 375mg, 500mg, 750mg controlled-rel tabs
Naprosyn 500mg tabs
125mg/
 
5mL
susp
EC-Naprosyn 375mg, 500mg e-c tabs
oxaprozin Daypro 600mg scored caplets
PROPIONIC ACIDS DERIVATIVE + H2 BLOCKER
ibuprofen + famotidine Duexis 800mg/26.6mg tabs      
PROPIONIC ACIDS DERIVATIVE + PROTON PUMP INHIBITOR
naproxen + esomeprazole Vimovo 375mg/20mg, 500mg/20mg del-rel tabs  
OXICAMS DERIVATIVES
meloxicam Mobic 7.5mg, 15mg tabs
piroxicam Feldene 10mg, 20mg caps
SALICYLATES
aspirin Bayer OTC 325mg tabs, caplets, gelcaps
Ecotrin OTC 81mg, 325mg e-c tabs
Extra Strength Bayer OTC 500mg caplets, gelcaps
choline magnesium trisalicylate 500mg, 750mg, 1g scored tabs
500mg/
 
5mL
soln
diflunisal 250mg, 500mg tabs
salsalate 500mg, 750mg scored tabs
NOTES

Key: e-c = enteric coated; supp = suppositories; susp = suspension;  *pH dependent coated pellets; A fixed-combination tablet indicated for the relief of signs/symptoms of arthritis (eg, RA, OA) and to reduce the risk of developing NSAID-induced GI ulcers.

FDA approved indications are marked with a ✓. Not an inclusive list of medications and/or official indications. Please see drug monograph at www.eMPR.com and/or contact company for full drug labeling.

(Rev. 5/2021)